make a nursing care plan on severe hypoglycemia ;assessment include subjective and objectice data , nursing diagnosis , goals , planning , implementation , rationale , evaluation
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive clinical data from authoritative textbooks. Let me compile the complete nursing care plan.
Nursing Care Plan: Severe Hypoglycemia
ASSESSMENT
Subjective Data (Patient/Family Reports)
| # | Subjective Finding |
|---|---|
| 1 | Patient or family reports recent insulin or sulfonylurea use without adequate food intake |
| 2 | Complaints of sudden onset shakiness, trembling, or weakness |
| 3 | Reports of sweating, palpitations, or feeling the heart "racing" |
| 4 | Complaints of dizziness, headache, or blurred vision |
| 5 | Reports of extreme hunger or nausea |
| 6 | Family states patient became "confused," "acting strange," or "unresponsive" |
| 7 | History of skipped meals, unaccustomed physical activity, alcohol ingestion, or medication overdose |
| 8 | Patient may report inability to concentrate or speak clearly |
| 9 | History of recurrent hypoglycemic episodes (hypoglycemia unawareness) |
Objective Data (Nurse Observes/Measures)
| # | Objective Finding |
|---|---|
| 1 | Blood glucose (BG) level below 54 mg/dL (Level 2) OR altered mental status requiring third-party assistance (Severe) |
| 2 | Diaphoresis (profuse sweating), pallor, cool clammy skin |
| 3 | Tachycardia (HR >100 bpm), elevated blood pressure |
| 4 | Neurological: confusion, agitation, slurred speech, combativeness |
| 5 | Altered level of consciousness - drowsiness progressing to stupor or coma |
| 6 | Seizure activity (possible) |
| 7 | Tremors and muscle weakness observable on exam |
| 8 | Inability to follow commands or protect airway |
| 9 | Bedside capillary blood glucose critically low on glucometry |
| 10 | Signs of aspiration risk if vomiting present (glucagon side effect) |
Clinical note: The Washington Manual of Medical Therapeutics classifies severe hypoglycemia as altered mental status requiring assistance for recovery. Symptoms result from two pathways: sympathetic-adrenal activation (sweating, anxiety, tremor, tachycardia from epinephrine release) and neuroglycopenia (fatigue, confusion, seizures, coma as glucose falls further).
NURSING DIAGNOSES
| # | NANDA Nursing Diagnosis |
|---|---|
| 1 | Risk for Unstable Blood Glucose Level related to inadequate food intake, insulin/sulfonylurea excess, or hypoglycemia unawareness |
| 2 | Acute Confusion related to neuroglycopenia (insufficient glucose delivery to brain) |
| 3 | Risk for Injury related to altered level of consciousness, seizures, and impaired motor coordination |
| 4 | Ineffective Airway Clearance related to loss of consciousness, seizure activity, and risk of aspiration |
| 5 | Risk for Aspiration related to altered consciousness and vomiting (especially post-glucagon) |
| 6 | Deficient Knowledge related to hypoglycemia prevention, recognition, and self-management |
| 7 | Anxiety related to life-threatening hypoglycemic episode and fear of recurrence |
GOALS
| Nursing Diagnosis | Short-Term Goal (within 1-4 hours) | Long-Term Goal (before discharge) |
|---|---|---|
| Unstable blood glucose | BG will return to ≥70 mg/dL within 30 minutes of treatment | Patient maintains BG within individualized target range; no recurrent severe episodes |
| Acute confusion | Patient regains full orientation (person, place, time) within 1 hour of glucose restoration | Patient demonstrates intact cognition with normal neurological assessment |
| Risk for injury | Patient sustains no physical injury (fall, trauma) during hypoglycemic episode | Patient and family verbalize safety measures during hypoglycemic events |
| Ineffective airway clearance | Airway remains patent; oxygen saturation ≥95% throughout event | Patient maintains effective breathing pattern at discharge |
| Risk for aspiration | Patient shows no signs of aspiration (no respiratory distress, clear lung sounds) | No aspiration-related complications develop |
| Deficient knowledge | Patient identifies 3 early warning signs of hypoglycemia by end of shift | Patient correctly demonstrates self-treatment protocol and glucagon kit use before discharge |
| Anxiety | Patient reports reduced anxiety as BG normalizes | Patient expresses confidence in managing future hypoglycemic events |
PLANNING
- Establish IV access immediately for drug and fluid administration
- Prioritize airway, breathing, circulation (ABC) assessment
- Gather emergency equipment at bedside: suction, oxygen, glucometer, D50W, glucagon kit
- Place patient in lateral (recovery) position if unconscious to reduce aspiration risk
- Initiate continuous glucose monitoring or scheduled glucometry every 15-30 minutes
- Coordinate with physician/endocrinologist for medication review and adjustment
- Plan patient and family teaching session on hypoglycemia prevention and glucagon use
- Plan nutrition consult for meal planning and carbohydrate consistency
IMPLEMENTATION (Nursing Interventions)
Priority 1 - Immediate Rescue Interventions
| Intervention | Details |
|---|---|
| Check BG immediately | Obtain capillary blood glucose at bedside; draw serum sample before giving dextrose (to measure insulin, C-peptide, proinsulin later if needed) |
| IV Dextrose 50% (D50W) | Administer 20-50 mL IV bolus immediately for severe hypoglycemia with altered consciousness; provides 25 g of glucose per 50 mL |
| Repeat dose if needed | If BG remains low after 15 minutes, repeat D50W bolus; begin D5W or D10W infusion to maintain BG >100 mg/dL |
| Glucagon IM/SC | Give glucagon 1 mg IM or SC when IV access cannot be secured; advise family/caregivers on autoinjector or nasal spray use |
| Oral carbohydrates | For patients who are conscious and can protect their airway: give 15-20 g fast-acting carbohydrates (glucose tablets, sugar-containing beverages); follow with a complex carbohydrate snack once BG recovers |
Priority 2 - Safety and Monitoring
| Intervention | Details |
|---|---|
| Continuous BG monitoring | Check BG every 15-30 minutes initially, then every 30-60 minutes for at least 2 hours; watch for rebound hypoglycemia |
| Neurological checks | Assess LOC, GCS, orientation every 15-30 minutes; document response to treatment |
| Airway protection | Position unconscious patient in left lateral decubitus (recovery position); suction available; prepare supplemental oxygen |
| IV line patency | Maintain patent IV access throughout episode; use large bore for reliable glucose delivery |
| Fall prevention | Apply side rails, bed alarm; call light within reach once patient regains consciousness; assist with ambulation |
| Seizure precautions | Pad side rails; do NOT restrain; have suction and airway adjuncts at bedside |
| Vital signs | Monitor HR, BP, RR, SpO2 frequently; tachycardia and diaphoresis should resolve as BG normalizes |
Priority 3 - Post-Stabilization Interventions
| Intervention | Details |
|---|---|
| Identify and remove precipitating cause | Review insulin dose, meal timing, physical activity, alcohol use, medication changes |
| Medication review | Collaborate with physician to adjust insulin or sulfonylurea dose; sulfonylurea-induced hypoglycemia may persist and require 24+ hours observation |
| Complex carbohydrate feeding | Once patient is conscious and able to swallow safely, provide a meal with complex carbohydrates to prevent recurrence |
| Continuous glucose monitoring (CGM) | Initiate or reinforce CGM with low-alarm settings for patients with hypoglycemia unawareness |
| Reassess at-risk populations | Elderly patients and those with defective counterregulation require prolonged IV dextrose infusion and extended observation |
Priority 4 - Patient and Family Education
| Intervention | Details |
|---|---|
| Recognition of warning signs | Teach the early (autonomic) symptoms: sweating, tremor, palpitations, anxiety, hunger |
| "Rule of 15" | Consume 15 g fast carbohydrates, wait 15 minutes, recheck BG - repeat if still below 70 mg/dL |
| Glucagon kit training | Demonstrate glucagon autoinjector or nasal spray to family/caregivers; stress importance of positioning patient on side to prevent aspiration |
| Hypoglycemia unawareness | Counsel patients on slightly relaxing glycemic control targets temporarily if unawareness has developed; frequent SMBG or CGM use |
| Carry fast-acting glucose | Advise patient to always carry glucose tablets or sugar source |
| Medical alert ID | Encourage wearing a diabetes medical alert bracelet |
| Avoid alcohol on an empty stomach | Alcohol impairs gluconeogenesis and is a significant trigger in insulin-treated patients |
RATIONALE
| Intervention | Rationale |
|---|---|
| IV D50W bolus | Dextrose 50% rapidly restores circulating glucose, reversing neuroglycopenia; 50 mL provides 25 g glucose and typically raises BG by 25-50 mg/dL quickly (Tintinalli's Emergency Medicine) |
| Follow with D5W/D10W infusion | Prevents rebound hypoglycemia after initial bolus wears off; maintains BG >100 mg/dL (The Washington Manual of Medical Therapeutics) |
| Glucagon 1 mg IM/SC | Stimulates hepatic glycogenolysis and gluconeogenesis; effective when IV access is unavailable; available as autoinjector and nasal spray for out-of-hospital use |
| Draw serum sample before glucose | Preserves the diagnostic "window" to determine insulin, C-peptide, and proinsulin levels - this opportunity is lost once dextrose is given (Tintinalli's Emergency Medicine) |
| Recovery position (lateral) | Reduces aspiration risk; vomiting is a frequent side effect of glucagon; unconscious patients cannot protect their airway |
| BG checks every 15-30 minutes | Sulfonylurea-induced hypoglycemia can recur for 24 hours; rebound hypoglycemia can occur even after initial correction |
| Seizure precautions | Profound neuroglycopenia can precipitate generalized tonic-clonic seizures; padded rails and suction prevent injury and airway compromise |
| Education on hypoglycemia unawareness | Recurrent hypoglycemia blunts autonomic responses and counterregulatory hormone secretion; patients lose warning symptoms and face higher risk for severe episodes (The Washington Manual of Medical Therapeutics) |
| CGM with alarm | Technology-based prevention; low-alert alarms prompt corrective action before BG drops to dangerous levels |
| Octreotide (in sulfonylurea cases) | Somatostatin analogue that suppresses insulin secretion; superior to glucose alone in sulfonylurea-induced hypoglycemia; negates ongoing drug effect (Tintinalli's Emergency Medicine) |
EVALUATION
| Nursing Diagnosis | Evaluation Criteria | Expected Outcome |
|---|---|---|
| Unstable blood glucose | BG readings at 15, 30, 60, 120 minutes post-intervention | BG ≥70 mg/dL within 30 minutes; stable >100 mg/dL at 2 hours; no rebound hypoglycemia in 24 hours |
| Acute confusion | GCS score, orientation to person/place/time | Patient fully oriented with GCS 15 within 1 hour of BG normalization |
| Risk for injury | Incident reports, skin and musculoskeletal assessment | No falls, lacerations, fractures, or head injury documented |
| Ineffective airway clearance | SpO2, respiratory rate and effort, lung auscultation | SpO2 ≥95% on room air; clear breath sounds bilaterally; no stridor or aspiration pneumonia |
| Risk for aspiration | Chest X-ray if clinically indicated, lung sounds | No aspiration pneumonia; patient swallowing safely before oral intake is resumed |
| Deficient knowledge | Return demonstration of glucagon use; verbalization of warning signs and the Rule of 15 | Patient/family correctly demonstrates glucagon administration; patient names at least 3 early warning symptoms and describes 2 preventive strategies |
| Anxiety | Patient self-report, observable affect, vital signs | Patient reports feeling calm and prepared; HR and BP normalized; patient expresses understanding of discharge plan |
Sources:
- The Washington Manual of Medical Therapeutics, Hypoglycemia section (Classification, Risk Factors, Diagnosis, Treatment)
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide, Chapter 224 (Hypoglycemia Management, D50W dosing, serum sampling strategy, octreotide)
- Harrison's Principles of Internal Medicine 22E, Hypoglycemia in Diabetes chapter
- Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, Hypoglycemia section
This is a shared conversation. Sign in to Orris to start your own chat.